P&
Paulson & Co. Inc.
13F filer · CIK 0001035674Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$2.58BU.S. long equity reported on 13F
Positions81 new · 2 closed
Net flow last quarter-$274MBuys minus sells
Top 10 positions weight100.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 20268 positions | |||||
| $720M | 27.94% | 5.80% | -3.8% | Q2 2023 | |
| $672M | 26.07% | 25.86% | Not reported | Q1 2021 | |
| $418M | 16.23% | 16.40% | -24.5% | Q3 2019 | |
| $361M | 14.02% | 19.59% | Not reported | Q3 2018 | |
| $208M | 8.07% | 39.94% | +4.9% | Q2 2013 | |
| $163M | 6.31% | 6.21% | Not reported | Q2 2013 | |
| $33.3M | 1.29% | 19.01% | Not reported | Q4 2020 | |
| $1.77M | 0.07% | 0.00% | Not reported | Q4 2024 | |
| Q1 2026Reported May 15, 20269 positions | |||||
| $910M | 29.23% | 25.89% | Not reported | Q1 2021 | |
| $729M | 23.42% | 6.04% | -18.5% | Q2 2023 | |
| $421M | 13.54% | 21.68% | Not reported | Q3 2019 | |
| $396M | 12.71% | 19.62% | Not reported | Q3 2018 | |
| $245M | 7.86% | 6.21% | Not reported | Q2 2013 | |
| $229M | 7.36% | 38.06% | +41.8% | Q2 2013 | |
| $159M | 5.11% | 0.16% | Not reported | Q2 2013 | |
| $23.1M | 0.74% | 19.04% | +94.2% | Q4 2020 | |
| ATFOLDAmicus Therapeutics, Inc. | $469K | 0.02% | 0.01% | New | Q1 2026 |
| Q4 2025Reported Feb 17, 20269 positions | |||||
| $994M | 30.48% | 7.48% | -10.5% | Q2 2023 | |
| $783M | 24.01% | 26.06% | Not reported | Q1 2021 | |
| $509M | 15.61% | 19.77% | +3.5% | Q3 2018 | |
| $364M | 11.16% | 21.68% | Not reported | Q3 2019 | |
| $254M | 7.78% | 6.69% | Not reported | Q2 2013 | |
| $133M | 4.07% | 0.16% | Not reported | Q2 2013 | |
| $131M | 4.01% | 33.79% | Not reported | Q2 2013 | |
| $67.8M | 2.08% | 0.88% | +2691.6% | Q4 2025 | |
| $26.3M | 0.81% | 9.92% | +1.6% | Q4 2020 | |
| Q3 2025Reported Nov 14, 202510 positions | |||||
| $875M | 29.46% | 8.40% | -8.7% | Q2 2023 | |
| $654M | 22.04% | 30.06% | Not reported | Q1 2021 | |
| $456M | 15.37% | 19.10% | +115.8% | Q3 2018 | |
| $373M | 12.56% | 21.62% | -13.5% | Q3 2019 | |
| $240M | 8.07% | 6.69% | Not reported | Q2 2013 | |
| $132M | 4.45% | 0.16% | Not reported | Q2 2013 | |
| $115M | 3.88% | 33.79% | Not reported | Q2 2013 | |
| $51.6M | 1.74% | 9.82% | Not reported | Q4 2020 | |
| $42.1M | 1.42% | 0.03% | Not reported | Q1 2025 | |
| $30.1M | 1.01% | 8.72% | Not reported | Q3 2016 | |
Premium opens every quarter this fund has filed